KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Change in Account Payables: 2009-2024

Historic Change in Account Payables for Nektar Therapeutics (NKTR) over the last 16 years, with Dec 2024 value amounting to $2.7 million.

  • Nektar Therapeutics' Change in Account Payables fell 42.84% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.9 million, marking a year-over-year increase of 44.97%. This contributed to the annual value of $2.7 million for FY2024, which is 192.51% up from last year.
  • Latest data reveals that Nektar Therapeutics reported Change in Account Payables of $2.7 million as of FY2024, which was up 192.51% from -$2.9 million recorded in FY2023.
  • In the past 5 years, Nektar Therapeutics' Change in Account Payables registered a high of $3.1 million during FY2022, and its lowest value of -$11.7 million during FY2021.
  • Its 3-year average for Change in Account Payables is $962,333, with a median of $2.7 million in 2024.
  • As far as peak fluctuations go, Nektar Therapeutics' Change in Account Payables slumped by 590.76% in 2021, and later surged by 192.51% in 2024.
  • Over the past 5 years, Nektar Therapeutics' Change in Account Payables (Yearly) stood at $2.4 million in 2020, then plummeted by 590.76% to -$11.7 million in 2021, then surged by 126.54% to $3.1 million in 2022, then slumped by 192.94% to -$2.9 million in 2023, then spiked by 192.51% to $2.7 million in 2024.